Shares of Tenet Healthcare Corporation (NYSE:THC - Get Free Report) crossed below its 50 day moving average during trading on Thursday. The stock has a 50 day moving average of $268.85 and traded as low as $259.37. Tenet Healthcare shares last traded at $263.57, with a volume of 1,511,694 shares traded.
Analysts Set New Price Targets
Several equities analysts recently commented on the company. Piper Sandler set a $308.00 target price on Tenet Healthcare in a report on Monday, July 27th. Mizuho set a $305.00 price objective on Tenet Healthcare in a report on Monday, November 2nd. Barclays boosted their target price on Tenet Healthcare from $271.00 to $297.00 and gave the stock an "overweight" rating in a research note on Wednesday, November 4th. Deutsche Bank increased their price target on shares of Tenet Healthcare from $260.00 to $320.00 and gave the company a "buy" rating in a research note on Friday, October 30th. Finally, Royal Bank Of Canada boosted their price target on shares of Tenet Healthcare from $283.00 to $304.00 and gave the company an "outperform" rating in a research report on Monday, November 2nd. Nineteen equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company's stock. According to MarketBeat, the company has an average rating of "Moderate Buy" and an average price target of $296.65.
Read Our Latest Analysis on Tenet Healthcare
Tenet Healthcare Stock Performance
The company has a current ratio of 1.58, a quick ratio of 1.52 and a debt-to-equity ratio of 1.76. The stock has a market cap of $20.98 billion, a price-to-earnings ratio of 7.64, a PEG ratio of 1.45 and a beta of 1.20. The stock's 50 day moving average is $268.85 and its two-hundred day moving average is $226.64.
Tenet Healthcare (NYSE:THC - Get Free Report) last posted its quarterly earnings data on Thursday, October 29th. The company reported $6.64 EPS for the quarter, beating analysts' consensus estimates of $4.68 by $1.96. Tenet Healthcare had a net margin of 13.09% and a return on equity of 28.22%. The company had revenue of $6.28 billion for the quarter, compared to analyst estimates of $5.49 billion. During the same period in the previous year, the business posted $3.70 earnings per share. Tenet Healthcare's quarterly revenue was up 6.5% on a year-over-year basis. Analysts anticipate that Tenet Healthcare Corporation will post 22.32 earnings per share for the current fiscal year.
Insider Activity
In other Tenet Healthcare news, Director J. Robert Kerrey sold 12,010 shares of the company's stock in a transaction on Monday, September 14th. The shares were sold at an average price of $263.72, for a total transaction of $3,167,277.20. Following the completion of the transaction, the director owned 4,794 shares in the company, valued at approximately $1,264,273.68. This represents a 71.47% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Lisa Y. Foo sold 24,000 shares of Tenet Healthcare stock in a transaction dated Monday, August 31st. The shares were sold at an average price of $266.32, for a total transaction of $6,391,680.00. Following the completion of the sale, the executive vice president directly owned 8,053 shares in the company, valued at approximately $2,144,674.96. The trade was a 74.88% decrease in their position. The SEC filing for this sale provides additional information. Over the last quarter, insiders sold 99,462 shares of company stock valued at $27,081,234. 0.97% of the stock is currently owned by company insiders.
Institutional Investors Weigh In On Tenet Healthcare
A number of institutional investors have recently added to or reduced their stakes in the business. V Square Quantitative Management LLC purchased a new position in shares of Tenet Healthcare during the 3rd quarter worth approximately $26,000. Mather Group LLC. boosted its stake in shares of Tenet Healthcare by 126.9% in the third quarter. Mather Group LLC. now owns 118 shares of the company's stock valued at $30,000 after buying an additional 66 shares in the last quarter. Trust Co. of Vermont purchased a new stake in shares of Tenet Healthcare in the second quarter valued at approximately $37,000. MADDEN SECURITIES Corp acquired a new position in Tenet Healthcare during the third quarter worth $38,000. Finally, Compass Financial Management LLC purchased a new position in Tenet Healthcare in the second quarter worth $57,000. Hedge funds and other institutional investors own 95.44% of the company's stock.
Tenet Healthcare Company Profile
(
Get Free Report)
Tenet Healthcare Corporation is a U.S.-based healthcare services company that operates acute care hospitals and provides related inpatient and outpatient services. Its hospitals offer services across areas such as emergency care, surgery, imaging and specialty treatment. Through its subsidiary United Surgical Partners International (USPI), Tenet also operates ambulatory surgery centers and surgical hospitals, providing outpatient surgical and procedural care. The company's Conifer Health Solutions business provides revenue cycle management and other administrative services to healthcare providers.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Tenet Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tenet Healthcare wasn't on the list.
While Tenet Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.
This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.